PL2689767T3 - Kompozycje i sposoby ich stosowania do poprawy stanu i wyglądu skóry - Google Patents

Kompozycje i sposoby ich stosowania do poprawy stanu i wyglądu skóry

Info

Publication number
PL2689767T3
PL2689767T3 PL13181653T PL13181653T PL2689767T3 PL 2689767 T3 PL2689767 T3 PL 2689767T3 PL 13181653 T PL13181653 T PL 13181653T PL 13181653 T PL13181653 T PL 13181653T PL 2689767 T3 PL2689767 T3 PL 2689767T3
Authority
PL
Poland
Prior art keywords
skin
appearance
improving
condition
methods
Prior art date
Application number
PL13181653T
Other languages
English (en)
Other versions
PL2689767T4 (pl
Inventor
Laurence Dryer
Dmitri Ptchelintsev
Original Assignee
Avon Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Products, Inc. filed Critical Avon Products, Inc.
Publication of PL2689767T3 publication Critical patent/PL2689767T3/pl
Publication of PL2689767T4 publication Critical patent/PL2689767T4/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13181653.0T 2004-12-22 2005-11-28 Sposoby poprawy stanu i wyglądu skóry PL2689767T4 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/021,073 US7514092B2 (en) 2004-12-22 2004-12-22 Compositions and methods of their use for improving the condition and appearance of skin
EP05852369A EP1827362A4 (en) 2004-12-22 2005-11-28 COMPOSITIONS AND METHODS OF USE FOR IMPROVING THE STATE AND THE APPEARANCE OF THE SKIN
PCT/US2005/043066 WO2006068786A2 (en) 2004-12-22 2005-11-28 Compositions and methods of their use for improving the condition and appearance of skin
EP13181653.0A EP2689767B1 (en) 2004-12-22 2005-11-28 Methods for improving the condition and appearance of skin

Publications (2)

Publication Number Publication Date
PL2689767T3 true PL2689767T3 (pl) 2019-09-30
PL2689767T4 PL2689767T4 (pl) 2019-11-29

Family

ID=36596037

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13181653.0T PL2689767T4 (pl) 2004-12-22 2005-11-28 Sposoby poprawy stanu i wyglądu skóry

Country Status (11)

Country Link
US (1) US7514092B2 (pl)
EP (2) EP2689767B1 (pl)
JP (1) JP5312795B2 (pl)
CN (1) CN101068525B (pl)
BR (1) BRPI0518953B1 (pl)
CA (1) CA2588128C (pl)
ES (1) ES2736304T3 (pl)
HK (1) HK1110508A1 (pl)
PL (1) PL2689767T4 (pl)
TR (1) TR201909138T4 (pl)
WO (1) WO2006068786A2 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351745B2 (en) * 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
EP2063860A1 (en) * 2006-09-20 2009-06-03 Chanel Parfums Beauté Cosmetic use of active agents that stimulate matriptase expression
EP2136797A4 (en) * 2007-04-17 2013-08-21 Codman & Shurtleff INTRANASAL ADMINISTRATION OF CURCUMINE IN A HELIUM GAS BOLUS FOR THE TREATMENT OF MORBUS ALZHEIMER
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
KR101416993B1 (ko) * 2007-06-20 2014-07-08 (주)바이오케어 주름개선용 화장료 조성물
US7745670B2 (en) * 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
US7985776B2 (en) * 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
JP2010018544A (ja) * 2008-07-10 2010-01-28 Nippon Zettoc Co Ltd 抗菌剤、口腔用組成物及び義歯洗浄剤
KR101615900B1 (ko) * 2008-10-31 2016-04-28 (주)아모레퍼시픽 커큐마 잔소리자를 유효성분으로 함유하는 피부 노화 방지용 조성물
US20100166677A1 (en) 2008-12-30 2010-07-01 Avon Products, Inc. Use of Tiliacora Triandra in Cosmetics and Compositions Thereof
US7723515B1 (en) * 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
EP2582382B1 (en) 2010-06-17 2017-04-19 New York University Cosmetic uses and applications of calreticulin
MX2012013787A (es) 2010-06-30 2012-12-17 Avon Prod Inc Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel.
US8771758B2 (en) 2010-06-30 2014-07-08 Avon Products, Inc. Use of Tiliacora triandra in cosmetics and compositions thereof
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
US8632827B2 (en) 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
CN111700838A (zh) * 2012-04-20 2020-09-25 宝洁公司 用于改善面部毛孔外观的组合物和方法
US20130289438A1 (en) * 2012-04-28 2013-10-31 Core Fitness And Wellness, Llc Weight Loss Method and Apparatus
AU2013327415A1 (en) * 2012-10-01 2015-05-07 Natura Cosmeticos S.A. Plant lipid composition for modulating functions of keratinous materials, method for modulating said functions and use of said plant lipids
WO2014164047A1 (en) * 2013-03-11 2014-10-09 Avon Products, Inc Antidesma bunius extracts and methods of use
WO2014158792A1 (en) * 2013-03-14 2014-10-02 Avon Products, Inc Allamanda cathartica extracts and methods of use
WO2014158797A1 (en) * 2013-03-14 2014-10-02 Avon Products, Inc Calotropis gigantea extracts and methods of use
JP5705939B2 (ja) * 2013-09-30 2015-04-22 染井　正徳 Ｎ−アシルトリプタミンを含有する組成物
US20150161528A1 (en) * 2013-12-09 2015-06-11 Amadeus S.A.S. Automated detection of travel incidents and rebooking of travel itineraries impacted by same
MY176528A (en) * 2014-01-07 2020-08-13 Sirim Berhad A method for producing nanolipid formulation for skin care and/or repair and a nanolipid formulation of the same
WO2015138502A1 (en) * 2014-03-11 2015-09-17 Gary Cleary In-situ skin regeneration for epidermolysis bullosa and other skin disorders
FR3052978B1 (fr) 2016-06-23 2020-01-31 Biotechmarine Procede d'obtention d'un extrait d'armeria maritima enrichi en diglycosides et son utilisation en cosmetique
PL237872B1 (pl) * 2016-08-01 2021-06-14 Adamed Consumer Healthcare Spolka Akcyjna Kompozycja do stosowania na skórę
IT201700104536A1 (it) * 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico
TW202014179A (zh) * 2018-10-09 2020-04-16 大江生醫股份有限公司 白雪花萃取物用於皮膚淡斑與改善皮膚皺紋的用途
CN114392393A (zh) * 2021-12-17 2022-04-26 重庆米茜尔医疗美容门诊部有限公司 一种用于皮肤自我修复的皮下注射组合物及其使用方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4820724A (en) 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
US5223262A (en) 1989-02-23 1993-06-29 University Of Utah Transdermal delivery system utilizing one way membranes
US4956171A (en) 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5146846A (en) 1990-05-01 1992-09-15 F. H. Maloney Company Roller assembly for grain shellers
US5466455A (en) * 1990-10-18 1995-11-14 Huffstutler, Jr.; Miles C. Polyphase fluid-extraction process, resulting products and methods of use
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
FR2695561B1 (fr) * 1992-09-17 1994-12-02 Lvmh Rech Gie Composition cosmétique ou dermatologique contenant au moins une saponine de type ginsenoside, et ses applications, notamment pour le soin des cheveux.
SE9403494L (sv) * 1994-10-13 1996-04-14 Aga Ab Sätt och anordning vid blekning av returfiber
JPH08283172A (ja) * 1995-04-14 1996-10-29 Kose Corp 活性酸素消去剤及びこれを含有する皮膚外用剤
FR2737215B1 (fr) * 1995-07-25 1997-10-17 Rhone Poulenc Chimie Polyorganosiloxanes perhalogenes et leurs procedes d'obtention
US5834513A (en) 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5847003A (en) 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
GB9704904D0 (en) * 1997-03-10 1997-04-30 Riley Fletcher Foundation The Essential oil composition
US5997889A (en) * 1998-02-20 1999-12-07 Omnipotent Skin Products, L.L.C. Hand and body creme for the treatment of skin ailments
FR2779058B1 (fr) * 1998-05-29 2003-02-21 Dior Christian Parfums Utilisation d'au moins une saponine ou un sapogenol cosmetiquement acceptable, comme agent cosmetique destine a augmenter la quantite de collagene iv dans la jonction dermo-epidermique
US6539946B2 (en) * 1998-11-13 2003-04-01 Rudolf Weyergans Alternating pressure method for cellulite reduction
US6224877B1 (en) * 1999-09-16 2001-05-01 Council Of Scientific And Industrial Research Process for extraction of curcuminoids from curcuma species
JP2001220312A (ja) * 2000-02-09 2001-08-14 Ichimaru Pharcos Co Ltd 植物水蒸気蒸留水含有化粧料組成物
JP4213836B2 (ja) * 2000-02-09 2009-01-21 株式会社マンダム 育毛剤組成物
US7736661B1 (en) 2000-03-07 2010-06-15 Avon Products, Inc Method of treating skin conditions
EP1145709A1 (de) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
EP1149578A1 (de) * 2000-04-28 2001-10-31 Laboratoires Serobiologiques(Societe Anonyme) Kosmetische oder pharmazeutische Zubereitungen mit Extraken der Pflanze Argania spinosa
JP4413387B2 (ja) * 2000-07-12 2010-02-10 丸善製薬株式会社 コラーゲン産生促進剤、エラスターゼ活性阻害剤、コラゲナーゼ活性阻害剤及び皮膚化粧料
KR100439425B1 (ko) * 2001-03-22 2004-07-05 (주)바이오케어 잔토리졸을 포함하는 조성물 및 그 용도
US6730469B2 (en) * 2001-07-05 2004-05-04 Fuji Photo Film Co., Ltd. Method and apparatus for liquid preparation of photographic reagent
US6979470B2 (en) * 2001-07-17 2005-12-27 Metaproteomics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
US6576269B1 (en) * 2001-09-06 2003-06-10 Alexander Y. Korneyev Treating open skin lesions using extract of sea buckthorn
JP2004002267A (ja) * 2002-03-28 2004-01-08 Kobayashi Pharmaceut Co Ltd コラゲナーゼ阻害剤及びその利用
JP2004075632A (ja) * 2002-08-21 2004-03-11 Noevir Co Ltd 真皮線維芽細胞賦活剤
JP2004256485A (ja) * 2003-02-27 2004-09-16 Takayuki Izumi 皮膚外用剤
FR2856297B1 (fr) * 2003-06-18 2005-08-05 Caster Utilisation de (2s,3r,4s)-4-hydroxyisoleucine dans des compositions cosmetiques pour application topique

Also Published As

Publication number Publication date
CA2588128C (en) 2014-10-14
TR201909138T4 (tr) 2019-07-22
EP1827362A2 (en) 2007-09-05
BRPI0518953B1 (pt) 2018-01-30
CA2588128A1 (en) 2006-06-29
PL2689767T4 (pl) 2019-11-29
WO2006068786A2 (en) 2006-06-29
US20060134059A1 (en) 2006-06-22
HK1110508A1 (en) 2008-07-18
WO2006068786A3 (en) 2007-04-19
CN101068525A (zh) 2007-11-07
JP5312795B2 (ja) 2013-10-09
ES2736304T3 (es) 2019-12-27
JP2008525447A (ja) 2008-07-17
EP2689767A1 (en) 2014-01-29
EP1827362A4 (en) 2012-08-29
CN101068525B (zh) 2012-05-23
EP2689767B1 (en) 2019-03-20
US7514092B2 (en) 2009-04-07
BRPI0518953A2 (pt) 2008-12-16

Similar Documents

Publication Publication Date Title
PL2689767T3 (pl) Kompozycje i sposoby ich stosowania do poprawy stanu i wyglądu skóry
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
PT1711070E (pt) Composição nutricional para melhorar o estado da pele e prevenir doenças de pele
IL176958A0 (en) Compounds and methods of use
ZA200701676B (en) Non-protein foaming composition and methods of making the same
IL183458A0 (en) Anti-il-1r1 single domain antibodies and therapeutic uses
ZA200702069B (en) Silver-releasing articles and methods of manufacture
IL182189A0 (en) Method and system for noninvasive cosmetic enhancement
IL188420A0 (en) Methods and compositions with enhanced therapeutic activity
ZA200710173B (en) Tygecycline and methods of preparing 9-nitrominocycline
EP1913112A4 (en) SUPPORTING AGENT AND METHODS OF USE
EP1967171A4 (en) SKIN PATCHES AND METHOD OF MANUFACTURE THEREOF
ZA200705489B (en) Methods for improving the structure and function of arterioles
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1789047A4 (en) PROCESS FOR TREATING DISEASES USING NALMEFENE AND ITS ANALOGUES
EP1786965A4 (en) LAMINATED PRODUCTS AND METHODS OF PRODUCING THE SAME
EP2002012A4 (en) METHOD FOR THE TREATMENT, REDUCTION AND INHIBITION OF AGE SKIN IN THE SKIN
EP1827111A4 (en) METHOD AND COMPOSITION FOR REDUCING THE APPEARANCE OF WRINKLES
EP1838288A4 (en) THERAPEUTIC MATERIALS AND METHODS
EP1735281A4 (en) SYNTHESIS OF INDENOISOQUINOLINIUMS AND TECHNIQUES OF USE
EP1737565A4 (en) COS CLAUS CONFIGURATIONS AND METHODS
IL181499A0 (en) Cosmetic compositions for improving skin appearance and uses thereof
EP1802737A4 (en) TISSUE SYSTEM AND USE METHOD
EP1601348A4 (en) Compositions and methods with improved therapeutic activity